NEW YORK, July 17, 2023 /PRNewswire/ -- The hemostats and tissue sealants market size is expected to increase to USD 2.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.82% according to Technavio.The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market's competitive landscape and offers information on several market vendors including Advanced Medical Solutions Group Plc, Artivion Inc., B. Braun SE, Baxter International Inc., Becton Dickinson and Co., BioCer Entwicklungs GmbH, Biomup SA, Cardinal Health Inc., CSL Ltd., Hemostasis LLC, Integra Lifesciences Holdings Corp., Johnson and Johnson, KATSAN KATGUT SANAYI VE TICARET A.S, Medtronic Plc, Pfizer Inc., Stryker Corp., Teijin Ltd., Teleflex Inc., Tricol Biomedical Inc., Vivostat AS. Download a Sample Report Now!
Hemostats and tissue sealants market insights -
- Vendors: 15+, Including Advanced Medical Solutions Group Plc, Artivion Inc., B. Braun SE, Baxter International Inc., Becton Dickinson and Co., BioCer Entwicklungs GmbH, Biomup SA, Cardinal Health Inc., CSL Ltd., Hemostasis LLC, Integra Lifesciences Holdings Corp., Johnson and Johnson, KATSAN KATGUT SANAYI VE TICARET A.S, Medtronic Plc, Pfizer Inc., Stryker Corp., Teijin Ltd., Teleflex Inc., Tricol Biomedical Inc., Vivostat AS among others
- Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
- Segments: Product (Hemostats, Tissue sealants and adhesives, and Fibrin sealants) and Geography (Europe, APAC, North America, South America, and Middle East and Africa)
To understand more about the information services market, request sample report
Hemostats and tissue sealants market - Customer Landscape
To help companies evaluate and develop growth strategies, the report outlines –
- Key purchase criteria
- Adoption rates
- Adoption lifecycle
- Drivers of price sensitivity
- For highlights on customer landscape analysis, download a sample!
Key Driver - One of the key factors driving the hemostats and tissue sealants market growth is the use of hemostats and tissue sealants in surgeries. Around the world, about 25 million surgeries are carried out each month. While surgical sealants can assist seal suture lines and prevent leaks, using hemostats during surgery can help to limit blood loss. Hemostasis can be achieved more quickly due to the use of hemostats, with less discomfort for the patient, and without the need for removal. Applications for hemostats and tissue sealants in minimally invasive operations are increasing. In the US and Europe alone, almost 950,000 laparoscopic surgeries are carried out annually. Thus, in minimally invasive surgeries and percutaneous interventional procedures, the intraoperative usage of hemostatic agents and tissue sealants has considerably increased. Hence, due to such factors, the market is expected to grow during the forecast period.
Leading Trend - Increasing R&D focus on novel hemostats and tissue sealants is one of the key hemostats and tissue sealants market trends that is expected to impact the market growth positively in the forecast period.
Significant challenge - One of the key challenges to the hemostats and tissue sealants market growth is the high cost of hemostats and tissue sealants which will impede the growth of the market.
Drivers, & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample report!
The hemostats and tissue sealants market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.
Why Buy?
- Add credibility to strategy
- Analyzes competitor's offerings
- Get a holistic view of the market
Grow your profit margin with Technavio- Buy the Report
What are the key data covered in this Hemostats And Tissue Sealants Market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the hemostats and tissue sealants market between 2022 and 2026
- Precise estimation of the hemostats and tissue sealants market size and its contribution to the market in focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the hemostats and tissue sealants market across Europe, APAC, North America, South America, and Middle East and Africa
- A thorough analysis of the market's competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of hemostats and tissue sealants market vendors
Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Related Reports:
The tissue engineering and regeneration market size is estimated to grow by USD 21.27 billion at a CAGR of 14.93% between 2022 and 2027. Technavio has segmented the market into material, application, and geography. The material segment is classified into synthetic, biological, and genetically modified. The application segment is classified into orthopedic, musculoskeletal and spine, dermatology, neurology, and others. The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW). The increasing detection of chronic diseases will drive the market growth during the forecast period,
The hemostats market size is predicted to surge to USD 925.79 million from 2021 to 2026 at a CAGR of 6.15%. This hemostats market segmentation by type (Matrix and gel hemostats, Sheet and pad hemostats, Sponge hemostats, and Powder hemostats) geography (North America, Europe, Asia, and Rest of World (ROW)). The growing volume of surgical procedures performed is notably driving the hemostats market growth during the forecast period.
Hemostats And Tissue Sealants Market Scope |
|
Report Coverage |
Details |
Base year |
2021 |
Historic period |
2017-2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.82% |
Market growth 2022-2026 |
USD 2.24 billion |
Market structure |
Fragmented |
YoY growth 2022-2023 (%) |
9.3 |
Regional analysis |
Europe, APAC, North America, South America, and Middle East and Africa |
Performing market contribution |
North America at 46% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advanced Medical Solutions Group Plc, Artivion Inc., B. Braun SE, Baxter International Inc., Becton Dickinson and Co., BioCer Entwicklungs GmbH, Biomup SA, Cardinal Health Inc., CSL Ltd., Hemostasis LLC, Integra Lifesciences Holdings Corp., Johnson and Johnson, KATSAN KATGUT SANAYI VE TICARET A.S, Medtronic Plc, Pfizer Inc., Stryker Corp., Teijin Ltd., Teleflex Inc., Tricol Biomedical Inc., and Vivostat AS |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product
- 5.3 Hemostats - Market size and forecast 2021-2026
- Exhibit 28: Chart on Hemostats - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Hemostats - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Hemostats - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Hemostats - Year-over-year growth 2021-2026 (%)
- 5.4 Tissue sealants and adhesives - Market size and forecast 2021-2026
- Exhibit 32: Chart on Tissue sealants and adhesives - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Tissue sealants and adhesives - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Tissue sealants and adhesives - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Tissue sealants and adhesives - Year-over-year growth 2021-2026 (%)
- 5.5 Fibrin sealants - Market size and forecast 2021-2026
- Exhibit 36: Chart on Fibrin sealants - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Fibrin sealants - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Fibrin sealants - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Fibrin sealants - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by Product
- Exhibit 40: Market opportunity by Product ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Canada - Market size and forecast 2021-2026
- Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.9 Germany - Market size and forecast 2021-2026
- Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 Advanced Medical Solutions Group Plc
- Exhibit 89: Advanced Medical Solutions Group Plc - Overview
- Exhibit 90: Advanced Medical Solutions Group Plc - Business segments
- Exhibit 91: Advanced Medical Solutions Group Plc - Key offerings
- Exhibit 92: Advanced Medical Solutions Group Plc - Segment focus
- 10.4 Artivion Inc.
- Exhibit 93: Artivion Inc. - Overview
- Exhibit 94: Artivion Inc. - Business segments
- Exhibit 95: Artivion Inc. - Key offerings
- Exhibit 96: Artivion Inc. - Segment focus
- 10.5 B. Braun SE
- Exhibit 97: B. Braun SE - Overview
- Exhibit 98: B. Braun SE - Business segments
- Exhibit 99: B. Braun SE - Key news
- Exhibit 100: B. Braun SE - Key offerings
- Exhibit 101: B. Braun SE - Segment focus
- 10.6 Baxter International Inc.
- Exhibit 102: Baxter International Inc. - Overview
- Exhibit 103: Baxter International Inc. - Business segments
- Exhibit 104: Baxter International Inc. - Key news
- Exhibit 105: Baxter International Inc. - Key offerings
- Exhibit 106: Baxter International Inc. - Segment focus
- 10.7 Becton Dickinson and Co.
- Exhibit 107: Becton Dickinson and Co. - Overview
- Exhibit 108: Becton Dickinson and Co. - Business segments
- Exhibit 109: Becton Dickinson and Co. - Key news
- Exhibit 110: Becton Dickinson and Co. - Key offerings
- Exhibit 111: Becton Dickinson and Co. - Segment focus
- 10.8 Integra Lifesciences Holdings Corp.
- Exhibit 112: Integra Lifesciences Holdings Corp. - Overview
- Exhibit 113: Integra Lifesciences Holdings Corp. - Business segments
- Exhibit 114: Integra Lifesciences Holdings Corp. - Key news
- Exhibit 115: Integra Lifesciences Holdings Corp. - Key offerings
- Exhibit 116: Integra Lifesciences Holdings Corp. - Segment focus
- 10.9 Johnson and Johnson
- Exhibit 117: Johnson and Johnson - Overview
- Exhibit 118: Johnson and Johnson - Business segments
- Exhibit 119: Johnson and Johnson - Key news
- Exhibit 120: Johnson and Johnson - Key offerings
- Exhibit 121: Johnson and Johnson - Segment focus
- 10.10 Medtronic Plc
- Exhibit 122: Medtronic Plc - Overview
- Exhibit 123: Medtronic Plc - Business segments
- Exhibit 124: Medtronic Plc - Key news
- Exhibit 125: Medtronic Plc - Key offerings
- Exhibit 126: Medtronic Plc - Segment focus
- 10.11 Pfizer Inc.
- Exhibit 127: Pfizer Inc. - Overview
- Exhibit 128: Pfizer Inc. - Product / Service
- Exhibit 129: Pfizer Inc. - Key news
- Exhibit 130: Pfizer Inc. - Key offerings
- 10.12 Teleflex Inc.
- Exhibit 131: Teleflex Inc. - Overview
- Exhibit 132: Teleflex Inc. - Business segments
- Exhibit 133: Teleflex Inc. - Key news
- Exhibit 134: Teleflex Inc. - Key offerings
- Exhibit 135: Teleflex Inc. - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 136: Inclusions checklist
- Exhibit 137: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 138: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 139: Research methodology
- Exhibit 140: Validation techniques employed for market sizing
- Exhibit 141: Information sources
- 11.5 List of abbreviations
- Exhibit 142: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
Share this article